In all the excitement over the potential for a quick vaccine to prevent COVID-19, one burning question has emerged: Are the antibodies that form in response to the virus adequate for fending off future infections? Scientists led by Harvard University have published two studies that they believe begin to answer that question.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,